Business · 11/12/2009
FDA Extends Comment Period for Postmarketing Safety Reporting for Combination Products
The Food and Drug Administration (FDA) is extending the comment period for a proposed rule on postmarketing safety reporting requirements for combination products until January 29, 2009, in response to requests for an extension from interested persons.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →